  To fulfill needs in oncological research a new Micromegas detector has been
developed to follow radiolabelled drugs in living organisms at the single cell
level. This article describes the proof-of-concept of such a detector and
compares its ability to detect and assess sub-becquerel \tritium~activities
with a commercial $\beta$-imager
